CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. (Q53455078)

14 May 2018

title

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. (English)

1 reference

14 May 2018

main subject

anti-retroviral agent

0 references

Matthias Cavassini

4

0 references

Manuel Battegay

9

object named as

Manuel Battegay

1 reference

PubMed ID

18783328

14 May 2018

Swiss HIV Cohort Study

11

object named as

Swiss HIV Cohort Study

1 reference

14 May 2018

6

Enos Bernasconi

1 reference

14 May 2018

8

Bernard Hirschel

1 reference

14 May 2018

3

Hansjakob Furrer

1 reference

14 May 2018

Matthias Egger

1 reference

ORCID Public Data File 2021

author name string

Nina Khanna

1

1 reference

14 May 2018

Milos Opravil

2

1 reference

14 May 2018

Pietro Vernazza

5

1 reference

14 May 2018

Rainer Weber

7

1 reference

14 May 2018

Gilbert R Kaufmann

10

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 October 2008

1 reference

14 May 2018

Clinical Infectious Diseases

published in

1 reference

14 May 2018

volume

47

1 reference

14 May 2018

issue

8

1 reference

14 May 2018

page(s)

1093-1101

1 reference

14 May 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

cites work

1 reference

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

21 January 2018

1 reference

Immunological recovery and antiretroviral therapy in HIV-1 infection

21 January 2018

1 reference

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study

21 January 2018

1 reference

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

21 January 2018

1 reference

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

21 January 2018

1 reference

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

21 January 2018

1 reference

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

21 January 2018

1 reference

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).

21 January 2018

1 reference

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study

21 January 2018

1 reference

Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study

21 January 2018

1 reference

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

21 January 2018

1 reference

Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.

21 January 2018

1 reference

Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort

21 January 2018

1 reference

The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics

21 January 2018

1 reference

Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials

21 January 2018

1 reference

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

21 January 2018

1 reference

Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

21 January 2018

1 reference

Class-sparing regimens for initial treatment of HIV-1 infection

21 January 2018

1 reference

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

21 January 2018

1 reference

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

21 January 2018

1 reference

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/592113

1 reference

14 May 2018

PubMed ID

18783328

1 reference

14 May 2018